查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447028

2030 年維吉尼亞市場預測：按類型、動物、分銷管道、應用和地區進行的全球分析

Virginiamycin Market Forecasts to 2030 - Global Analysis By Type (Poultry, Aquaculture and Other Types), Animal (Companion Animals, Cattle, Swine and Other Animals), Distribution Channel, Application and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球維吉尼亞市場規模為 1.8505 億美元，預計預測期內年複合成長率為 7.5%，到 2030 年將達到 3.0701 億美元。

維吉尼亞是一種強效抗生素，也可用作牲畜和家禽的飼料添加劑，以促進生長並防止細菌感染。這種抗生素由兩種密切相關的成分（維吉尼亞M1 和維吉尼亞S1）組成，屬於鏈黴素組。此外，這些元素還可以透過阻止細胞內的蛋白質合成來抑制細菌生長。其對革蘭氏陽性菌的出色功效使維吉尼亞黴素成為疾病預防和促進動物健康的寶貴工具。

根據美國獸醫協會 (AVMA) 的說法，負責任地使用抗生素（包括維吉尼亞等化合物）對於確保農業環境中動物的健康和福祉至關重要。

增加畜牧業產量

全球畜產品需求不斷成長是推動維吉尼亞市場的主要因素之一。隨著世界人口持續成長以滿足對肉類和乳製品日益成長的需求，高效和永續的畜牧生產變得越來越重要。此外，維吉尼亞是有利於集中畜牧業實踐的主要因素，因為它有助於預防感染疾病並促進牲畜生長。

對抗生素抗藥性的擔憂

對抗生素抗藥性的日益擔憂是影響維吉尼亞市場的主要因素之一。在家畜中廣泛且持續地使用維吉尼亞黴素等抗生素可能是導致抗藥性細菌出現的因素。此外，抗藥性細菌可以透過食物鏈傳播給人類，不僅使牲畜而且使公共衛生面臨風險。它還會降低抗生素的長期有效性。

擴大精準畜牧業的使用

在自動化、資料分析和感測器技術進步的推動下，維吉尼亞市場預計將受益於精準畜牧業的日益成長。此外，可以精確應用維吉尼亞和其他飼料添加劑，以最大限度地提高生長和健康結果。精密農業可以更精確地監測動物健康參數和飼料效率。

加強監管約束

加強對畜牧生產中抗生素使用的監管審查和收緊法規對維吉尼亞市場構成了嚴重威脅。對抗生素抗藥性的擔憂導致各國政府和國際組織制定更嚴格的法規，這可能會限制維吉尼亞的供應和使用。此外，市場參與企業還面臨遵守不斷變化的監管標準的挑戰。

COVID-19 的影響：

由於供應鏈中斷、勞動力短缺和經濟不確定性影響了整個農業和畜牧業，COVID-19 大流行對維吉尼亞市場產生了重大影響。疫情帶來的關閉和限制造成了物流挑戰，阻礙了維吉尼亞等飼料添加劑的生產和分銷。此外，由於經濟衝擊，一些家牛生產者重新考慮了他們的支出，這可能會影響這些添加劑的市場。

預計在預測期內家禽市場將成為最大的市場

家禽養殖佔維吉尼亞市場的最大佔有率。家禽業廣泛使用維吉尼亞作為飼料添加劑，以促進生長並保護雞和其他家禽免受細菌感染。由於人口成長和飲食偏好的變化，世界對家禽產品的持續需求，對有效和永續的家禽養殖的需求正在增加。此外，維持雞群健康和產量的有用工具是維吉尼亞，因為它具有對抗革蘭氏陽性菌的效力。

牛和家禽飼料添加劑領域預計在預測期內年複合成長率最高。

牛和家禽飼料添加劑是年複合成長率最高的維吉尼亞市場。由於對肉類和家禽產品的需求不斷增加以及對永續動物生產方法的需求，該市場正在顯著擴大。維吉尼亞是一種抗生素飼料添加劑，因其治療和預防牛和家禽疾病（如球蟲和壞死性小腸結腸炎）的能力而受到高度重視。此外，它還能刺激生長，提高飼料轉換效率，促進體重增加，並改善動物的整體健康狀況。

佔比最大的地區：

北美可能佔據維吉尼亞市場的最大佔有率。北美地區畜牧業發達，對肉禽產品的需求量大，是維吉尼亞的主要消費國。以維吉尼亞作為牛和家禽飼料添加劑也受到該地區嚴格的食品安全和動物健康法規的影響。此外，推廣永續動物生產方法也是北美的重點優先事項，支持該地區維吉尼亞市場的擴張。

年複合成長率最高的地區：

預計亞太地區維吉尼亞市場的年複合成長率最高。在亞太地區，作為牛和家禽飼料添加劑的維吉尼亞的需求大幅增加。這一成長的主要驅動力是由於人口成長、可支配收入增加和飲食偏好變化而導致的肉類和家禽產品消費量的增加。此外，該地區正在轉向更加集中的畜牧方式，因此需要使用維吉尼亞等抗生素來預防感染疾病並促進生長。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球維吉尼亞市場：依類型

  • 家禽
  • 水產養殖
  • 其他類型

第6章全球維吉尼亞市場：依動物分類

  • 伴同性動物
  • 牛
  • 豬
  • 其他動物

第7章全球維吉尼亞市場：按分銷管道

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章全球維吉尼亞市場：依應用分類

  • 壞死性小腸結腸炎
  • 球蟲
  • 生長刺激
  • 牛和家禽飼料添加劑
  • 其他用途

第9章全球維吉尼亞市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Elanco
  • Merck Animal Health
  • Ceva
  • Merial
  • Bayer Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol
  • Boehringer Ingelheim
  • Virbac
  • Zoetis
Product Code: SMRC25289

According to Stratistics MRC, the Global Virginiamycin Market is accounted for $185.05 million in 2023 and is expected to reach $307.01 million by 2030 growing at a CAGR of 7.5% during the forecast period. Virginiamycin is a strong antibiotic that is also used as a feed additive in livestock and poultry farming to boost growth and guard against bacterial infections. Virginiamycin M1 and Virginiamycin S1, its two closely related components, make up this antibiotic that is a member of the streptogramin group. Additionally, these elements suppress bacterial growth by preventing protein synthesis in the cells. Due to its exceptional efficacy against Gram-positive bacteria, Virginiamycin is a valuable tool for disease prevention and enhancing animal health in general.

According to the American Veterinary Medical Association (AVMA), the responsible use of antibiotics, including compounds such as Virginiamycin, is crucial in ensuring the health and well-being of animals in agricultural settings.

Market Dynamics:

Driver:

Increasing production of livestock

The growing demand for livestock products worldwide is one of the major factors driving the Virginiamycin market. To meet the rising demand for meat and dairy products, efficient and sustainable livestock production is becoming more and more important as the world's population continues to rise. Moreover, virginiamycin is a major factor in favor of intensive animal farming practices because it helps to prevent infections and promote growth in livestock.

Restraint:

Antibiotic resistance concerns

The increasing worry about antibiotic resistance is one of the major factors affecting the Virginiamycin market. The widespread and ongoing use of antibiotics, such as Virginiamycin, in cattle may be a factor in the emergence of bacterial strains that are resistant. Furthermore, due to the fact that resistant bacteria may spread to humans via the food chain, this puts public health at risk in addition to that of animals. It also reduces the antibiotics' long-term efficacy.

Opportunity:

Growing use of accurate livestock production

The market for virginiamycin is expected to benefit from the increasing use of precision livestock farming, which is being fueled by developments in automation, data analytics, and sensor technologies. Moreover, virginiamycin and other feed additives can be applied precisely to maximize growth and health outcomes. Precision farming makes it possible to monitor animal health parameters and feed efficiency more precisely.

Threat:

Growing restraints on regulations

The increasing regulatory scrutiny and tightening restrictions on the use of antibiotics in livestock farming pose a serious threat to the Virginiamycin market. Stricter regulations are being put in place by governments and international organizations in response to worries about antibiotic resistance, which may restrict the supply and use of Virginiamycin. Furthermore, market participants face challenges in adhering to changing regulatory standards.

Covid-19 Impact:

Due to supply chain disruptions, labor shortages, and economic uncertainties that have impacted the entire agriculture and livestock industry, the COVID-19 pandemic has had a significant impact on the Virginiamycin market. Lockdowns and restrictions brought on by the pandemic created logistical difficulties that hampered the manufacture and distribution of feed additives, such as Virginiamycin. Moreover, some cattle producers have reevaluated their expenditures as a result of the economic fallout, which could affect the market for these additives.

The Poultry segment is expected to be the largest during the forecast period

In the market for Virginiamycin, poultry farming has the largest share. To encourage growth and guard against bacterial infections in hens and other poultry species, the poultry industry uses Virginiamycin as a feed additive liberally. The need for effective and sustainable poultry farming practices has grown as a result of the world's constant demand for poultry products, which is being driven by population growth and shifting food preferences. Additionally, a useful tool for preserving the wellbeing and output of chicken flocks is Virginiamycin, due to its potency against Gram-positive bacteria.

The Feed Additive for Cattle and Poultry segment is expected to have the highest CAGR during the forecast period

Feed Additive for Cattle and Poultry is the Virginiamycin market segment with the highest CAGR. Due to the rising demand for meat and poultry products as well as the necessity of using sustainable animal production methods, this market is expanding significantly. The antibiotic feed additive virginiamycin is highly prized for its ability to treat and prevent diseases in cattle and poultry, including coccidiosis and necrotic enteritis. Furthermore, it also stimulates growth, increasing feed conversion effectiveness, encouraging weight gain, and improving the general health of the animal.

Region with largest share:

North America is probably the region with the largest share of the Virginiamycin market. Because of its well-established livestock industry and strong demand for meat and poultry products, North America is a major consumer of Virginiamycin. The adoption of Virginiamycin as a feed additive for cattle and poultry is also influenced by the region's strict regulations regarding food safety and animal health. Moreover, the promotion of sustainable animal production methods is another major priority in North America, which supports the expansion of the Virginiamycin market there.

Region with highest CAGR:

The Asia-Pacific region is anticipated to have the highest CAGR in the Virginiamycin market. The demand for Virginiamycin as a feed additive for cattle and poultry is rising significantly in the Asia-Pacific area. The growing population, rising disposable income, and shifting dietary preferences-which result in a greater consumption of meat and poultry products-are the main drivers of this growth. Furthermore, the area is witnessing a transition towards more intensive methods of animal husbandry, thereby requiring the application of antibiotics such as Virginiamycin to prevent infections and enhance growth.

Key players in the market

Some of the key players in Virginiamycin market include Elanco, Merck Animal Health, Ceva, Merial, Bayer Animal Health, Phibro Animal Health Corporation, Vetoquinol, Boehringer Ingelheim, Virbac and Zoetis.

Key Developments:

In November 2023, CEVA Logistics completed its acquisition of Stellar Value Chain. CEVA acquired a 96% stake in the Mumbai-based warehousing and transportation specialists from an affiliate of private equity form Warburg Pincus and other shareholders. The acquisition adds to CEVA's existing presence in India, allowing for the delivery of holistic supply chain services to customers across the Asia Pacific region and beyond.

In August 2023, Merck Animal Health announced Dec. 6 that it has acquired Prondil S.A., a privately held company specializing in the development and manufacturing of animal health vaccines for livestock. Specific terms of the agreement were not disclosed. Prondil, located in Montevideo, Uruguay, is an internationally recognized supplier of antigens and vaccines for veterinary use. The company's wide range of products is sold in more than 20 countries.

In May 2023, Elanco Animal Health Incorporated has entered into an agreement with Aptimmune Biologics, Inc., as the exclusive distributor of their porcine reproductive and respiratory syndrome inactivated, or killed, vaccine based on Aptimmune's Barricade technology platform in the United States. An inactivated vaccine is one consisting of virus particles, bacteria or other pathogens that have been grown in culture and then killed to destroy disease-producing capacity.

Types Covered:

  • Poultry
  • Aquaculture
  • Other Types

Animals Covered:

  • Companion Animals
  • Cattle
  • Swine
  • Other Animals

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Applications Covered:

  • Necrotic enteritis
  • Coccidiosis
  • Growth Stimulation
  • Feed Additive for Cattle and Poultry
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • sAsia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Virginiamycin Market, By Type

  • 5.1 Introduction
  • 5.2 Poultry
  • 5.3 Aquaculture
  • 5.4 Other Types

6 Global Virginiamycin Market, By Animal

  • 6.1 Introduction
  • 6.2 Companion Animals
  • 6.3 Cattle
  • 6.4 Swine
  • 6.5 Other Animals

7 Global Virginiamycin Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Retail Pharmacies
  • 7.4 Online Pharmacies

8 Global Virginiamycin Market, By Application

  • 8.1 Introduction
  • 8.2 Necrotic enteritis
  • 8.3 Coccidiosis
  • 8.4 Growth Stimulation
  • 8.5 Feed Additive for Cattle and Poultry
  • 8.6 Other Applications

9 Global Virginiamycin Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Elanco
  • 11.2 Merck Animal Health
  • 11.3 Ceva
  • 11.4 Merial
  • 11.5 Bayer Animal Health
  • 11.6 Phibro Animal Health Corporation
  • 11.7 Vetoquinol
  • 11.8 Boehringer Ingelheim
  • 11.9 Virbac
  • 11.10 Zoetis

List of Tables

  • Table 1 Global Virginiamycin Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 4 Global Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 5 Global Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 7 Global Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 8 Global Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 9 Global Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 10 Global Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 11 Global Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 12 Global Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 13 Global Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 14 Global Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 15 Global Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 17 Global Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 18 Global Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 19 Global Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 20 Global Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 North America Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 23 North America Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 24 North America Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 25 North America Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 26 North America Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 27 North America Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 28 North America Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 29 North America Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 30 North America Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 31 North America Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 32 North America Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 33 North America Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 34 North America Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 35 North America Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 37 North America Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 38 North America Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 39 North America Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 40 North America Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Europe Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 43 Europe Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 44 Europe Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 45 Europe Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 46 Europe Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 47 Europe Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 48 Europe Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 49 Europe Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 50 Europe Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 51 Europe Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 52 Europe Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 53 Europe Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 54 Europe Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 55 Europe Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 56 Europe Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 57 Europe Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 58 Europe Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 59 Europe Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 60 Europe Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 61 Asia Pacific Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 63 Asia Pacific Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 64 Asia Pacific Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 65 Asia Pacific Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 66 Asia Pacific Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 67 Asia Pacific Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 68 Asia Pacific Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 69 Asia Pacific Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 70 Asia Pacific Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 71 Asia Pacific Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 72 Asia Pacific Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 73 Asia Pacific Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 74 Asia Pacific Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 75 Asia Pacific Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 76 Asia Pacific Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 77 Asia Pacific Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 78 Asia Pacific Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 79 Asia Pacific Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 80 Asia Pacific Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 81 South America Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 83 South America Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 84 South America Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 85 South America Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 86 South America Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 87 South America Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 88 South America Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 89 South America Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 90 South America Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 91 South America Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 92 South America Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 93 South America Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 94 South America Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 95 South America Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 96 South America Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 97 South America Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 98 South America Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 99 South America Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 100 South America Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 101 Middle East & Africa Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 104 Middle East & Africa Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 105 Middle East & Africa Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 106 Middle East & Africa Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 107 Middle East & Africa Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 108 Middle East & Africa Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 109 Middle East & Africa Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 110 Middle East & Africa Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 111 Middle East & Africa Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 112 Middle East & Africa Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 113 Middle East & Africa Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 114 Middle East & Africa Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 115 Middle East & Africa Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 116 Middle East & Africa Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 117 Middle East & Africa Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 118 Middle East & Africa Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 119 Middle East & Africa Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 120 Middle East & Africa Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)